Application is supported by results from the DEVOTE study, which suggested that two doses of Spinraza (nusinerse) 50 mg taken ...

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

Paul Howe, chief commercial officer at Protega, discusses efforts to combine high tech solutions with pain-management medications.

As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...

The cobas liat test aims to improve patient outcomes by offering rapid, accurate results in decentralized and community-based ...

Arvinas, Inc, announced that its chief commercial officer, John Northcott, is stepping down as of mid-January. 1 While the ...

The trial, developed in collaboration with Novotech, will specifically target dietary and alcohol-induced overindulgence.

PharmaScroll announced a new generative AI chatbot called Self-Serve AI. 1 The company describes it as a research and ...

Viralgen and Axovia Therapeutics are partnering to develop and manufacture a gene therapy for the treatment of retinal dystrophy in patients with Bardet-Biedl Syndrome (BBS) caused by biallelic ...

The two organizations will produce educational materials about the medicine and its importance for people living with type 1 ...

Expanded GTM services aim to ensure members receive tests at the optimal times while cutting down on testing misuse.

CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD).